AiVita Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

AiVita Biomedical Inc (AiVita) is a biotechnology company developing novel stem cell technologies to develop cell-based treatments and healthcare products for the treatment of cancer, vision loss, and skincare formulations. Its lead therapeutic candidate is a patient-specific immunotherapy for the treatment of advanced cancers, glioblastoma and ovarian cancer. The companys preclinical programs include human stem cells differentiated into sheets of retinal tissue to treat degenerative retinal diseases; and anti-aging skin care technology. AiVita is focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. AiVita Biomedical is headquartered in Irvine, California, the US.

AiVita Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AiVita Biomedical Raises USD15 Million in Series B Financing 10
AiVita Biomedical Raises Additional USD3.5 Million in Venture Financing 11
AiVita Biomedical Raises USD2 Million in Series A Financing 12
Licensing Agreements 13
Caladrius Biosciences Enters into Licensing Agreement with AiVita Biomedical 13
AiVita Biomedical Enters into Licensing Agreement with Caladrius Biosciences 14
AiVita Biomedical Inc - Key Competitors 15
AiVita Biomedical Inc - Key Employees 16
AiVita Biomedical Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Aug 16, 2018: AIVITA Biomedical appoints chief financial officer and vice president of business development 18
Sep 21, 2017: Renowned Dermatologist Dr. Michael H. Gold Joins AIVITA Scientific Advisory Board 19
May 03, 2017: AIVITA Biomedical names Ed Inal as Chief Operating Officer 20
Government and Public Interest 21
Jul 17, 2018: AIVITA Biomedical receives $1.7 million CIRM Grant to treat Vision loss 21
Sep 19, 2017: AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth 22
Product News 23
Jun 14, 2018: AIVITA Biomedical Randomizes First Patient in Phase II Ovarian Cancer Trial 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables


AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiVita Biomedical Raises USD15 Million in Series B Financing 10
AiVita Biomedical Raises Additional USD3.5 Million in Venture Financing 11
AiVita Biomedical Raises USD2 Million in Series A Financing 12
Caladrius Biosciences Enters into Licensing Agreement with AiVita Biomedical 13
AiVita Biomedical Enters into Licensing Agreement with Caladrius Biosciences 14
AiVita Biomedical Inc, Key Competitors 15
AiVita Biomedical Inc, Key Employees 16

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

AiVita Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AiVita Biomedical Inc (AiVita) is a biotechnology company developing novel stem cell technologies to develop cell-based treatments and healthcare products for the treatment of cancer, vision loss, and skincare formulations.

USD 250 View Report

Ondine Biomedical Inc - Product Pipeline Analysis, 2018 Update

Ondine Biomedical Inc (Ondine), formerly Ondine Biopharma Corp, a subsidiary of 0902337 B.C. Ltd, is a non-antibiotic anti-infective therapies developer for bacterial, viral, and fungal infections. The companys products include

USD 750 View Report

Saladax Biomedical Inc - Product Pipeline Analysis, 2018 Update

Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available